Difference between revisions of "Part:BBa K4165139"
(→Dry Lab) |
|||
(9 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K4165139 short</partinfo> | <partinfo>BBa_K4165139 short</partinfo> | ||
− | + | A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils. | |
+ | |||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
+ | TLKIVW is a hexapeptide designed using Rosetta software and obtained by phage display to bind to VQIVYK (BBa_K4165204) steric zipper motif of tau fibers, which is from the main reasons of the Alzheimer’s disease and other dementia related diseases, this peptide can also prevent further accumulation of tau fibrils. | ||
<!-- --> | <!-- --> | ||
− | <span class='h3bb'>Sequence and Features</span> | + | <span class='h3bb'> <p style=" font-weight: bold; font-size:17px;"> Sequence and Features</p> </span> |
<partinfo>BBa_K4165139 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165139 SequenceAndFeatures</partinfo> | ||
− | |||
===Dry Lab=== | ===Dry Lab=== | ||
Line 17: | Line 17: | ||
<p style=" font-weight: bold; font-size:14px;"> Modeling </p> | <p style=" font-weight: bold; font-size:14px;"> Modeling </p> | ||
− | TLKIVW | + | TLKIVW was modeled by AlphaFold2 and Apptest and the best model was obtained from Apptest ranking 5 out of 6 according to our quality assessment code. |
<html> | <html> | ||
− | < | + | <style> |
+ | table, th, td { | ||
+ | border:1px solid black; margin-left:auto;margin-right:auto; | ||
+ | } | ||
+ | </style> | ||
+ | <body> | ||
+ | |||
+ | <table style="width:65%"> | ||
+ | <table> | ||
+ | <tr> | ||
+ | <th>cbeta_deviations</th> | ||
+ | <th>molprobity</th> | ||
+ | <th>ramachandran_favored</th> | ||
+ | <th>ramachandran_outliers</th> | ||
+ | <th>Qmean_4</th> | ||
+ | <th>Qmean_6</th> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>0</td> | ||
+ | <td>2.11</td> | ||
+ | <td>100</td> | ||
+ | <td>0</td> | ||
+ | <td>-1.97474</td> | ||
+ | <td>-0.69185</td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | </body> | ||
</html> | </html> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<html> | <html> | ||
− | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/tlkivw | + | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/tlkivw.png" style="margin-left:220px;" alt="" width="500" /></p> |
</html> | </html> | ||
+ | Figure 1: Predicted 3D structure of Synthetic peptide TLKIVW. | ||
===References=== | ===References=== | ||
− | 1.Sievers, S. A., Karanicolas, J., Chang, H. W., Zhao, A., Jiang, L., Zirafi, O., ... & Eisenberg, D. (2011). Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature, 475(7354), 96-100. | + | 1. Sievers, S. A., Karanicolas, J., Chang, H. W., Zhao, A., Jiang, L., Zirafi, O., ... & Eisenberg, D. (2011). Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature, 475(7354), 96-100. |
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Latest revision as of 11:36, 11 October 2022
TLKIVW Peptide
A synthetic peptide that is used for targeting misfolded tau protein (BBa_K4165009) as it binds to PHF6 of tau fibrils.
Usage and Biology
TLKIVW is a hexapeptide designed using Rosetta software and obtained by phage display to bind to VQIVYK (BBa_K4165204) steric zipper motif of tau fibers, which is from the main reasons of the Alzheimer’s disease and other dementia related diseases, this peptide can also prevent further accumulation of tau fibrils.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry Lab
Modeling
TLKIVW was modeled by AlphaFold2 and Apptest and the best model was obtained from Apptest ranking 5 out of 6 according to our quality assessment code.
cbeta_deviations | molprobity | ramachandran_favored | ramachandran_outliers | Qmean_4 | Qmean_6 |
---|---|---|---|---|---|
0 | 2.11 | 100 | 0 | -1.97474 | -0.69185 |
Figure 1: Predicted 3D structure of Synthetic peptide TLKIVW.
References
1. Sievers, S. A., Karanicolas, J., Chang, H. W., Zhao, A., Jiang, L., Zirafi, O., ... & Eisenberg, D. (2011). Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature, 475(7354), 96-100.